Androgen-Dependent Repression of ERRγ Reprograms Metabolism in Prostate Cancer.
How androgen signaling contributes to the oncometabolic state of prostate cancer remains unclear. Here, we show how the estrogen-related receptor γ (ERRγ) negatively controls mitochondrial respiration in prostate cancer cells. Sustained treatment of prostate cancer cells with androgens increased the activity of several metabolic pathways, including aerobic glycolysis, mitochondrial respiration, and lipid synthesis. An analysis of the intersection of gene expression, binding events, and motif analyses after androgen exposure identified a metabolic gene expression signature associated with the action of ERRγ. This metabolic state paralleled the loss of ERRγ expression. It occurred in both androgen-dependent and castration-resistant prostate cancer and was associated with cell proliferation. Clinically, we observed an inverse relationship between ERRγ expression and disease severity. These results illuminate a mechanism in which androgen-dependent repression of ERRγ reprograms prostate cancer cell metabolism to favor mitochondrial activity and cell proliferation. Furthermore, they rationalize strategies to reactivate ERRγ signaling as a generalized therapeutic approach to manage prostate cancer. Cancer Res; 77(2); 378-89. ©2016 AACR.
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.
Étienne
É
Audet-Walsh
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.
Tracey
T
Yee
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.|Department of Biochemistry, McGill University, Montréal, Québec, Canada.
Shawn
S
McGuirk
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.
Mathieu
M
Vernier
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.
Carlo
C
Ouellet
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.|Department of Biochemistry, McGill University, Montréal, Québec, Canada.
Julie
J
St-Pierre
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada. vincent.giguere@mcgill.ca.|Department of Biochemistry, McGill University, Montréal, Québec, Canada.|Departments of Medicine and Oncology, McGill University, Montréal, Québec, Canada.
Vincent
V
Giguère
D000728:Androgens / Q000378:metabolism; D000818:Animals; D045744:Cell Line, Tumor; D019069:Cell Respiration / Q000502:physiology; D047369:Chromatin Immunoprecipitation; D020869:Gene Expression Profiling; D064593:Heterografts; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D051379:Mice; D016133:Polymerase Chain Reaction; D016016:Proportional Hazards Models; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D011944:Receptors, Androgen / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D059467:Transcriptome
C410798:AR protein, human; D000728:Androgens; C490917:ESRRG protein, human; D011944:Receptors, Androgen; D011960:Receptors, Estrogen